Electrocardiograph (ECG) Market Size and Share

Electrocardiograph (ECG) Market Analysis by Mordor Intelligence
The Electrocardiograph (ECG) Market size is projected to be USD 7.81 billion in 2025, USD 8.43 billion in 2026, and reach USD 12.33 billion by 2031, growing at a CAGR of 7.92% from 2026 to 2031.
Demand is shifting from hospital-centric diagnostics toward distributed cardiac monitoring as AI-enabled interpretation, sub-USD 100 single-lead modules in wearables, and edge analytics in emergency vehicles reshape care pathways. Regulatory momentum accelerated after the U.S. FDA cleared 14 AI-ECG algorithms in 2025, double the 2024 count, confirming that machine-learning models trained on diverse cohorts are moving from pilot to production [1]U.S. Food and Drug Administration, “AI-ECG Clearances,” fda.gov. Government-funded screening is also scaling quickly: China’s National Health Commission mandated ECG tests for adults over 35 in tier-2 cities by 2027, creating outsized demand for portable, cloud-connected devices.
Payers are aligning incentives with technology adoption; the U.S. Centers for Medicare & Medicaid Services introduced CPT 93264 in January 2025, unlocking a USD 400 million reimbursement pool for remote monitoring vendors. Against this backdrop, cybersecurity incidents—such as a ransomware attack on a European platform that exposed 120,000 records in March 2025—underscore the need for robust data-protection frameworks.
Key Report Takeaways
- By product type, resting ECG Systems led with 45.87% revenue share in 2025, while wearable and patch ECG Devices are advancing at an 8.11% CAGR through 2031.
- By lead configuration, 12-lead units held 49.98% of the electrocardiograph (ECG) market share in 2025; 3–6-lead devices are growing at an 8.43% CAGR to 2031.
- By technology, digital and cloud-connected devices accounted for 73.23% of the electrocardiograph (ECG) market size in 2025 and are projected to register an 8.21% CAGR to 2031.
- By end user, hospitals and clinics generated 59.12% of 2025 revenue, whereas ambulatory surgical centers record the fastest growth at a 10.12% CAGR.
- By geography, North America captured 45.3% revenue share in 2025; Asia-Pacific is the fastest-expanding region with an 8.81% CAGR to 2031.
Note: Market size and forecast figures in this report are generated using Mordor Intelligence’s proprietary estimation framework, updated with the latest available data and insights as of January 2026.
Global Electrocardiograph (ECG) Market Trends and Insights
Driver Impact Analysis
| Driver | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Rising Cardiovascular-Disease Prevalence | +1.8% | Global; highest burden in Asia-Pacific and Eastern Europe | Long term (≥ 4 years) |
| Rapid Adoption of AI-Enabled ECG Devices | +1.5% | North America and EU lead; APAC accelerating | Medium term (2-4 years) |
| Accelerating Shift to Home & Remote Cardiac Monitoring | +1.3% | North America and EU mature; APAC emerging | Medium term (2-4 years) |
| Government-Funded Mass Screening Programs | +1.2% | Core in APAC, spill-over to MEA | Short term (≤ 2 years) |
| Edge-Computing ECG Analytics in Emergency Vehicles | +0.6% | North America & EU pilot; APAC urban centers | Medium term (2-4 years) |
| Sub-USD 99 Embedded Single-Lead Modules for OEMs | +0.9% | Global; fastest uptake in APAC | Short term (≤ 2 years) |
| Source: Mordor Intelligence | |||
Rising Cardiovascular-Disease Prevalence
Ischemic heart disease and stroke caused 17.9 million deaths in 2024 and are projected to reach 23 million by 2030, raising demand for early detection worldwide [2]World Health Organization, “Cardiovascular Disease Statistics,” who.int. India’s national program screened 150 million adults in 2025 with battery-operated devices that travel to rural clinics. Employers and payers recognize the USD 1.1 trillion annual economic burden, so reimbursement now favors longitudinal ECG monitoring instead of episodic testing. The result is a broader install base of portable systems in primary care and community centers.
Rapid Adoption of AI-Enabled ECG Devices
Fourteen AI-ECG algorithms cleared by the FDA in 2025 reflect regulator confidence in machine learning interpretation. Mayo Clinic’s platform cut time-to-diagnosis for myocardial infarction by 18 minutes in emergency departments that adopted it in 2025. Draft guidance on algorithmic fairness issued in September 2025 now requires validation across sex, race, and age, likely delaying launches yet building clinician trust. Urban hospitals are first movers because they have cloud infrastructure, while rural sites rely on manual reads. Vendors reply by embedding edge processors that run algorithms offline.
Accelerating Shift to Home & Remote Cardiac Monitoring
CMS created CPT 93264 in 2025, reimbursing 30-day remote ECG monitoring episodes and opening a USD 400 million annual revenue pool. AliveCor reported 42% year-over-year growth in KardiaMobile sales fueled by atrial-fibrillation patients capturing arrhythmias at home. Telehealth leaders such as Teladoc integrated ECG data streams so cardiologists adjust medication remotely. Europe lags as payers debate liability and data quality, but regulatory clarity is improving under MDR.
Government-Funded Mass Screening Programs
China’s ECG mandate for adults over 35 in tier-2 cities by 2027 will require 200 million tests annually [3]National Health Commission of China, “ECG Screening Mandate,” en.nhc.gov.cn. India earmarked INR 5,000 crore (USD 600 million) in 2025 for cardiovascular screening infrastructure, focusing on high-diabetes districts. The UAE’s national registry now obligates ECG uploads for every acute coronary syndrome case, weaving data compliance into purchasing criteria. These front-loaded programs accelerate procurement through 2027 before growth moderates.
Restraints Impact Analysis
| Restraint | (~) % Impact on CAGR Forecast | Geographic Relevance | Impact Timeline |
|---|---|---|---|
| Fragmented Reimbursement in Emerging Markets | -1.1% | APAC (ex-Japan), MEA, South America | Long term (≥ 4 years) |
| Shortage of ECG-Trained Technicians | -0.8% | Global; acute in rural APAC & Sub-Saharan Africa | Medium term (2-4 years) |
| Cyber-Security & Data-Privacy Risks | -0.6% | Global; scrutiny in EU & North America | Short term (≤ 2 years) |
| Algorithm Bias in Women & Dark-Skin Populations | -0.5% | Global; regulatory focus in US & EU | Medium term (2-4 years) |
| Source: Mordor Intelligence | |||
Fragmented Reimbursement in Emerging Markets
Patients in India, Brazil, and Indonesia still pay USD 50–150 out of pocket per monitoring episode because insurers lack standardized coverage, suppressing adoption in lower-income groups. Brazil’s last fee schedule update was in 2022, causing bilateral price negotiation and opacity that discourages distribution investment. If India’s Ayushman Bharat adds remote ECG to its package by 2027, harmonization could accelerate.
Shortage of ECG-Trained Technicians
The WHO projects an 18 million-worker deficit in low- and middle-income countries by 2030, including ECG technologists. U.S. training program enrollment fell 12% from 2023 to 2025 due to competition from higher-paid radiology roles. AI interpretation mitigates but does not eliminate the human requirement because regulators still mandate clinician sign-off. India’s Skill Development Corporation aims to train 50,000 technicians by 2028, yet the pipeline remains years away from closing gaps.
Segment Analysis
By Product Type: Wearables Challenge Resting Systems’ Dominance
Resting systems secured 45.87% of revenue in 2025, but wearables and patches posted the highest 8.11% CAGR as new CPT codes make remote monitoring financially attractive. Holter monitors lose share to 14-day patches such as Zio, which grew prescriptions 38% in 2025. Stress systems confront competition from coronary CT angiography because payers perceive a higher diagnostic yield. Software adds recurring revenue; Philips’ cloud platform integrates with Epic and Cerner using FHIR, reaching gross margins above 70%.
The wearables wave is reshaping procurement: consumer-electronics giants supply single-lead devices at minimal cost, pushing medical vendors to bundle multi-lead fidelity and analytics. The Electrocardiograph (ECG) market size for software is projected to expand faster than hardware due to the margin advantages. Hospitals retain cart-based resting systems for acute triage, but outpatients and home settings increasingly favor lightweight patches and watches.

Note: Segment shares of all individual segments available upon report purchase
By Lead Type: Multi-Lead Fidelity Versus Single-Lead Convenience
Twelve-lead models maintained 49.98% Electrocardiograph (ECG) market share in 2025 because guidelines still treat them as the diagnostic gold standard. Meanwhile, 3–6-lead devices rise at an 8.43% CAGR to serve ambulatory centers prioritizing rapid setup and portability. Single-lead wearables sold 45 million units in 2025; however, their limited spatial resolution yields higher false-positive rates, taxing cardiology referral systems.
Advanced 15/18-lead systems stay confined to academic centers: GE’s MAC 2000 costs more than USD 25,000 and needs expert placement. As payers do not reimburse extra leads, penetration remains niche. The Electrocardiograph (ECG) market size for 3-6-lead devices should widen as outpatient procedures grow, narrowing the gap with 12-lead carts.
By Technology: Cloud Connectivity Reshapes Data Workflows
Digital platforms captured 73.23% revenue in 2025 and will compound at 8.21% as hospitals demand real-time, interoperable cardiac data. Cloud hosting allows cardiologists to review tracings remotely, which became indispensable during pandemic restrictions. Analog devices persist in low-resource clinics where internet is unreliable. A ransomware breach in Europe spurred regulators to require encryption and penetration tests, increasing cost but favoring incumbents with security teams.
Digital uptake aligns with value-based care: population-health analytics depend on standardized FHIR datasets. Vendors that seamlessly link waveforms to electronic records win multi-year software-as-a-service contracts. The Electrocardiograph (ECG) market share for analog systems will continue to erode as procurement guidelines mandate cloud compatibility.

By End User: Ambulatory Centers Capture Outpatient Shift
Hospitals and clinics produced 59.12% of 2025 revenue, anchored by emergency departments that administer more than 150 million ECG tests annually in the United States. Yet ambulatory surgical centers clock a 10.12% CAGR because value-based contracts migrate catheter ablation and pacemaker implantation to outpatient settings. ASCs favor compact 3–6-lead systems that roll between procedure rooms.
Home and remote patients represent the absolute growth engine. Diagnostic labs see flat volumes in mature regions but rise in Asia-Pacific as insurance coverage widens. The Electrocardiograph (ECG) market size tied to home settings should surpass ASC revenue before 2031 if reimbursement parity persists.
Geography Analysis
Asia-Pacific records the fastest 8.81% CAGR through 2031 on the back of mass-screening mandates in China and India, local manufacturing by Mindray and EDAN, and smartphone penetration that supports Bluetooth-paired single-lead devices. Japan’s 28.4% senior population fuels home monitoring, while South Korea covers 30-day monitoring for atrial fibrillation. Australia halved software-approval timelines, enticing venture-backed entrants.
North America held 45.3% revenue in 2025, but growth moderates as hospital penetration nears saturation. CPT 93264 nevertheless channels fresh volume to wearable vendors. Canada trails because provincial budgets tighten, and Mexico’s federal procurement lingers in negotiation. Europe rebounded after MDR bottlenecks eased; Germany now funds four virtual cardiology visits annually for heart-failure patients.
The Middle East & Africa account for a notable share of revenue; the UAE registry requirement anchors future demand. South Africa purchased 5,000 portable units in 2025 to mitigate power-outage disruptions. South America wrestles with currency volatility; Brazil’s real depreciation raised import costs, steering buyers to lower-priced models.

Competitive Landscape
Moderate fragmentation defines the Electrocardiograph (ECG) market: the top five vendors, Philips, GE, Nihon Kohden, Schiller, and Medtronic, together hold majority share of global revenue. They compete on multi-lead fidelity, clinical validation, and EHR integration, justifying premiums of 30-50% over commodity devices. Consumer-electronics firms like Apple and Samsung command single-lead volume at negligible marginal cost but lack hospital clearances.
Startup dynamism is notable. AliveCor’s USD 99 KardiaMobile posted 42% sales growth in 2025. iRhythm’s Zio Patch prescriptions rose significantly, reflecting cardiologists’ preference for 14-day wear time. Edge analytics for emergency vehicles and sub-USD 99 embedded modules for automotive OEMs are emerging white spaces.
Cybersecurity is a new differentiator. Vendors achieving ISO 27001 certification win enterprise contracts as hospitals harden defenses after 2025 ransomware events. Asia-Pacific firms such as Mindray and EDAN capture cost-sensitive tenders by pricing 40-50% lower than Western peers without sacrificing cloud functionality.
Electrocardiograph (ECG) Industry Leaders
GE Healthcare
NIHON KOHDEN CORPORATION
Schiller AG
Medtronic Plc
Koninklijke Philips N.V.
- *Disclaimer: Major Players sorted in no particular order

Recent Industry Developments
- January 2026: AliveCor received FDA clearance expanding KAI 12L AI to 39 cardiac determinations.
- January 2026: AccurKardia obtained FDA 510(k) for AccurECG 2.0 enterprise analysis system.
- Jan 2026: Philips earned 510(k) for IntelliVue X3 portable monitor with integrated 12-lead ECG and edge analytics.
Global Electrocardiograph (ECG) Market Report Scope
As per the scope of the report, an electrocardiogram is a rapid, non-invasive medical test that records the electrical activity of the heart to assess its rhythm and function. During the procedure, small adhesive sensors called electrodes are placed on the chest, arms, and legs to detect minute electrical impulses generated by the heart's natural pacemaker, the sinoatrial (SA) node.
The electrocardiograph (ECG) market is segmented by product type, lead type, technology, end-user, and geography. By product type, it is segmented into resting ECH systems, stress ECH systems, Holter monitors, event recorders, and wearable / patch ECG devices, ECG management software. By lead type, the market is segmented into single-lead ECG, 3–6 lead ECG, 12-lead ECG, and others. By technology, the market is segmented into analog ECG devices and digital / cloud-connected ECG devices. By End users, the market is segmented into hospitals & clinics, ambulatory surgical centers, home settings / remote patients, diagnostic labs & cardiac centers.
Geographically, the market is segmented across North America, Europe, the Asia-Pacific region, the Middle East & Africa, and South America. The market report also covers the estimated market sizes and trends for 17 countries across major regions globally. For each segment, the market size and forecast are provided in terms of value (USD).
| Resting ECG Systems |
| Stress ECG Systems |
| Holter Monitors |
| Event Recorders |
| Wearable / Patch ECG Devices |
| ECG Management Software |
| Single-Lead ECG |
| 3–6 Lead ECG |
| 12-Lead ECG |
| Others |
| Hospitals & Clinics |
| Ambulatory Surgical Centers |
| Home Settings / Remote Patients |
| Diagnostic Labs & Cardiac Centers |
| Analog ECG Devices |
| Digital / Cloud-connected ECG Devices |
| North America | United States |
| Canada | |
| Mexico | |
| Europe | Germany |
| United Kingdom | |
| France | |
| Italy | |
| Spain | |
| Rest of Europe | |
| Asia-Pacific | China |
| India | |
| Japan | |
| South Korea | |
| Australia | |
| Rest of Asia-Pacific | |
| Middle East and Africa | GCC |
| South Africa | |
| Rest of Middle East and Africa | |
| South America | Brazil |
| Argentina | |
| Rest of South America |
| By Product Type | Resting ECG Systems | |
| Stress ECG Systems | ||
| Holter Monitors | ||
| Event Recorders | ||
| Wearable / Patch ECG Devices | ||
| ECG Management Software | ||
| By Lead Type | Single-Lead ECG | |
| 3–6 Lead ECG | ||
| 12-Lead ECG | ||
| Others | ||
| By End User | Hospitals & Clinics | |
| Ambulatory Surgical Centers | ||
| Home Settings / Remote Patients | ||
| Diagnostic Labs & Cardiac Centers | ||
| By Technology | Analog ECG Devices | |
| Digital / Cloud-connected ECG Devices | ||
| By Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Europe | Germany | |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Asia-Pacific | China | |
| India | ||
| Japan | ||
| South Korea | ||
| Australia | ||
| Rest of Asia-Pacific | ||
| Middle East and Africa | GCC | |
| South Africa | ||
| Rest of Middle East and Africa | ||
| South America | Brazil | |
| Argentina | ||
| Rest of South America | ||
Key Questions Answered in the Report
What growth rate is projected for the Electrocardiograph ECG market through 2031?
The market is forecast to advance at a 7.92% CAGR from 2026 to 2031.
Which product type is expanding fastest?
Wearable and patch ECG devices are growing at an 8.11% CAGR on the back of new reimbursement codes in major markets.
Why is Asia-Pacific the quickest-growing region?
Government-funded mass screening in China and India, coupled with local manufacturing scale-up, drives an 8.81% CAGR through 2031.
How are AI algorithms influencing device adoption?
FDA-cleared AI-ECG algorithms shorten diagnosis times and boost clinician confidence, accelerating the shift toward cloud-connected systems.
What cybersecurity measures are vendors adopting?
Following a major ransomware incident in 2025, leading suppliers now certify to ISO 27001 and implement end-to-end encryption across cloud platforms.




